OrbiMed’s Verrica Pharmaceuticals VRCA Stock Holding History

OrbiMed’s Portfolio VRCA Stock Details VRCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-147,973	Closed	-$18.5M	–	179
2021 Q3	$18.5M	Hold	147,973	–	–	0.2%	99
2021 Q2	$16.7M	Hold	147,973	–	–	0.17%	103
2021 Q1	$22.4M	Hold	147,973	–	–	0.21%	95
2020 Q4	$17M	Hold	147,973	–	–	0.15%	105
2020 Q3	$11.5M	Hold	147,973	–	–	0.14%	107
2020 Q2	$16.3M	Hold	147,973	–	–	0.23%	83
2020 Q1	$16.2M	Hold	147,973	–	–	0.27%	76
2019 Q4	$23.5M	Hold	147,973	–	–	0.34%	61
2019 Q3	$21.8M	Hold	147,973	–	–	0.42%	58
2019 Q2	$17.2M	Hold	147,973	–	–	0.27%	76
2019 Q1	$16M	Hold	147,973	–	–	0.25%	82
2018 Q4	$12.1M	Hold	147,973	–	–	0.23%	83
2018 Q3	$24M	Hold	147,973	–	–	0.29%	79
2018 Q2	$29.2M	Buy	+147,973	New	+$29M	0.35%	68

Other funds holding VRCA

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return